|
End-of-day quote
Korea S.E.
19/08/2026
|
5-day change | 1st Jan Change | ||
| 1,94,100.00 KRW | -0.72% |
|
-3.91% | +12.60% |
| 18/08 | Celltrion's Acquired French Healthcare Firm Becomes Fully Operational | MT |
| 04/08 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.72% | -3.91% | +10.41% | +11.67% | +12.60% | +17.87% | +47.98% | -12.88% | +142.51% | 3.17TCr | |
| +2.37% | +2.30% | +2.01% | +18.69% | +7.70% | +3.39% | +22.74% | -22.67% | +211.40% | 4.86TCr | |
| -0.62% | +4.58% | +15.31% | +45.73% | +169.50% | +487.47% | +624.71% | +772.96% | - | 4.63TCr | |
| +2.09% | +4.96% | +20.78% | +26.88% | +24.04% | +20.59% | +95.21% | +36.82% | +1,173.18% | 4.2TCr | |
| +3.85% | +3.13% | +20.86% | +43.94% | +10.59% | +29.60% | +16.50% | -2.88% | +232.15% | 3.95TCr | |
| +3.04% | +1.89% | +13.12% | +44.86% | +8.30% | +31.62% | +143.62% | +244.69% | +2,032.04% | 1.65TCr | |
| +4.33% | +1.63% | -0.53% | +9.09% | - | - | - | - | - | 1.63TCr | |
| +1.44% | +1.52% | +0.54% | +15.27% | +13.24% | +4.22% | +31.00% | -40.27% | +91.62% | 1.4TCr | |
| +3.87% | +1.98% | +29.26% | +90.25% | +45.38% | +82.99% | +45.80% | -31.01% | +250.83% | 1.33TCr | |
| +3.26% | +3.18% | +1.46% | +51.91% | -5.34% | -3.98% | -31.10% | -30.05% | +128.04% | 1.29TCr | |
| -5.28% | +1.15% | +36.56% | +84.01% | +70.42% | +61.55% | +78.26% | -43.57% | - | 1.27TCr | |
| +0.36% | +0.35% | +0.50% | +59.40% | +23.24% | +32.09% | -7.36% | -39.08% | +170.57% | 1.13TCr | |
| +4.42% | -0.04% | +22.83% | +20.45% | +31.03% | +762.13% | +1,687.92% | +54.82% | - | 1.03TCr | |
| +0.39% | -5.49% | -13.34% | +6.39% | -14.20% | +75.68% | +504.09% | +284.01% | +2,407.28% | 1.03TCr | |
| -1.53% | +1.93% | +9.96% | +57.51% | +77.40% | +175.45% | +709.93% | +221.25% | +1,213.05% | 1.02TCr | |
| +0.10% | +0.12% | +0.53% | +72.11% | +78.47% | +269.98% | +455.73% | - | - | 1.01TCr | |
| +4.89% | +11.65% | +9.97% | +62.93% | +63.62% | +199.06% | +545.59% | +144.78% | - | 1.01TCr | |
| +1.98% | +7.55% | +11.79% | -17.66% | -23.14% | +43.13% | +56.50% | +60.68% | +82.09% | 990.79Cr | |
| +1.49% | +5.54% | +11.67% | +71.02% | +76.87% | +203.37% | +119.53% | +513.37% | - | 915.03Cr | |
| +24.09% | +12.16% | +16.73% | +34.53% | +3.73% | -16.19% | - | - | - | 890.63Cr | |
| Average | +2.69% | +1.01% | +11.02% | +40.45% | +35.44% | +130.53% | +285.92% | +124.17% | +677.90% | 1.92TCr | |
| Weighted average by Cap. | +2.10% | +0.98% | +11.99% | +36.40% | +40.71% | +123.55% | +227.77% | +143.03% | +587.25% |
- Stock Market
- Stocks
- A068270 Stock
- Sector Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
